High-risk group is associated with C634 and A883 RET pathological variants, former being the commonest cause responsible for 90–95% of MEN2a and latter a rare and milder form of MEN2b (Wells et al. 2015). This evidence concerns the gene RET and multiple endocrine neoplasia type 2B.